These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3135178)

  • 1. Effect of leuprolide on growth of rat prostatic tumor (R 3327) and weight of male accessory sex organs.
    Ichikawa T; Akimoto S; Shimazaki J
    Endocrinol Jpn; 1988 Feb; 35(1):181-7. PubMed ID: 3135178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the gonadotropin-releasing hormone agonist [D-leu6, desgly-NH2(10), proethylamide9]-GnRH (leuprolide) on R3327-G rat prostatic tumor growth.
    Pollack A; Block NL; Stover BJ; Fuentes MP; Irvin GL
    J Urol; 1984 Feb; 131(2):399-403. PubMed ID: 6422059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adrenalectomy, flutamide, and leuprolide on the growth of the Dunning rat R-3327 prostatic carcinoma.
    Kung TT; Mingo GG; Siegel MI; Watnick AS
    Prostate; 1988; 12(4):357-63. PubMed ID: 3134647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
    Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ketoconazole on testosterone production and normal and malignant androgen dependent tissues of the adult rat.
    Trachtenberg J
    J Urol; 1984 Sep; 132(3):599-601. PubMed ID: 6088812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen on growth of androgen-responsive rat prostatic tumor (R 3327).
    Furuya Y; Sato N; Watabe Y; Shimazaki J
    Endocrinol Jpn; 1991 Feb; 38(1):67-73. PubMed ID: 1915114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotropin releasing hormone analogue in the rat.
    English HF; Santner SJ; Levine HB; Santen RJ
    Cancer Res; 1986 Jan; 46(1):38-42. PubMed ID: 3079588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
    Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
    J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.
    Schneider MR; Humm A; Graf AH
    J Cancer Res Clin Oncol; 1990; 116(2):159-67. PubMed ID: 2324159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of flutamide action on prostatic and testicular functions in the rat.
    Marchetti B; Labrie F
    J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881).
    van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT
    J Androl; 1997; 18(1):51-61. PubMed ID: 9089068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals.
    Ogawa Y; Okada H; Heya T; Shimamoto T
    J Pharm Pharmacol; 1989 Jul; 41(7):439-44. PubMed ID: 2570847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of testosterone and of a luteinizing hormone-releasing hormone agonist on androgen receptor content in the ventral prostate of castrated rats.
    Fiorelli G; Zoppi S; Kohen F; Motta M
    Steroids; 1989; 53(1-2):195-217. PubMed ID: 2505407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.
    Warner B; Worgul TJ; Drago J; Demers L; Dufau M; Max D; Santen RJ
    J Clin Invest; 1983 Jun; 71(6):1842-53. PubMed ID: 6408125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and clinical effects of leuprolide in prostatic cancer.
    Vance MA; Smith JA
    Clin Pharmacol Ther; 1984 Sep; 36(3):350-4. PubMed ID: 6432399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuprolide: a gonadotropin-releasing hormone analog for the palliative treatment of prostatic cancer.
    Wojciechowski NJ; Carter CA; Skoutakis VA; Bess DT; Falbe WJ; Mickle TR
    Drug Intell Clin Pharm; 1986 Oct; 20(10):746-51. PubMed ID: 2429815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leuprolide: a review of its effects in animals and man.
    Drago JR; Rohner T; Santen R; Manni A; Lipton A; Harvey H; English H
    Br J Clin Pract Suppl; 1985 Mar; 37():4-7, 16-9. PubMed ID: 3931664
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of prostatic cancer by LH-RH agonist.
    Imai K; Yamanaka H; Yuasa H; Yoshida M; Asano M; Kaetsu I
    Prog Clin Biol Res; 1987; 243A():429-34. PubMed ID: 3116552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.